Laekna Lae002 Lae001 Approval: Fda Phase 3 Prostate Cancer Trial
23 May 2024 //
PR NEWSWIRE
Laekna doses first subject in Phase I/II prostate cancer trial
06 Sep 2022 //
CLINICALTRIALSARENA
Innovent and Laekna begin Dosing with Three-drug Combination in PI/II Study
31 Jul 2022 //
PRNEWSWIRE
Laekna doses first subjects in Phase Ib/III breast cancer therapy trial
27 May 2022 //
CLINICALTRIALSARENA
Laekna Therapeutics Begins Dosing in PIb/III Study of Afuresertib + Fulvestrant
26 May 2022 //
PRNEWSWIRE
Novartis farms out rare disease drug to LifeMax Labs
28 Aug 2018 //
FIERCE BIOTECH